Keryx Biopharmaceuticals (KERX)

Add to Watchlists Create an Alert
15.39 +0.12  +0.79% NASDAQ Jul 30, 11:14AM BATS Real time Currency in USD
View Full Chart
KERX Price Chart
View All Events

KERX Events

Date Type Description
06/23/2014 Misc Annual General Meeting for Keryx Biopharmaceuticals Inc
05/08/2014 08:00 EDT Misc Keryx Biopharmaceuticals Inc Q1 2014 Earnings Conference Call
05/08/2014 Earnings Keryx Biopharmaceuticals Inc Q1 2014 Earnings Results. Estimate: -0.10.
03/13/2014 08:30 EDT Misc Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
03/13/2014 Earnings Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Results. Estimate: -0.19.
11/05/2013 08:30 EDT Misc Q3 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
11/04/2013 Earnings Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results. Estimate: -0.14.
08/01/2013 08:30 EDT Misc Q2 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
08/01/2013 Earnings Results for the Second Quarter Ended June 30, 2013. Estimate: -0.09.
View All Performance Charts

KERX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Keryx Biopharmaceuticals is up 72.73% over the last year vs S&P 500 Total Return up 19.10%, Kindred Biosciences up N/A, and PTC Therapeutics up 69.43%.

Get Quote for

PDF Report for KERX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download KERX Pro Report PDF

Portfolio Strategies Featuring KERX

Did Keryx Biopharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

KERX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Keryx Biopharmaceuticals, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It is developing ZerenexTM an oral, ferric iron-based compound.

KERX Excel Add-In Codes

  • Name: =YCI("KERX","name")
  • Description: =YCI("KERX","description")
  • Sector: =YCI("KERX","sector")
  • Industry: =YCI("KERX","industry")
  • Est. Current Fiscal Year End: =YCI("KERX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start your {{}} Membership


{{ ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{}} Member? Sign in here.